NeuroKaire (formerly Genetika+)

NeuroKaire's mission is to transform brain health and eliminate suffering through the integration of precision medicine into psychiatry and neurology. Through a simple blood test, NeuroKaire’s neuronal readout provides a new window into brain function, helping clinicians identify the optimal antidepressant based on the unique response of a patient's brain cells combined with their genetics and medical history. By eliminating trial-and-error protocols and optimizing treatments, NeuroKaire significantly improves patient outcomes and reduces side effects. The company’s innovative technology also provides pharmaceutical companies with essential tools for targeted drug discovery and development. Stay connected and learn more about our mission to revolutionize mental health: https://linktr.ee/NeuroKaire